Androgens are known to play a pivotal role in cardiovascular function. However, a definitive explanation as to how their impact differs between genders is yet to be provided. In this review, the existing studies on the link between androgens and cardiovascular disease have been analysed, with a particular focus on the gender-specific differences. Several studies agree that both direct and indirect effects of testosterone on cardiovascular function show a gender-related dimorphism. Consistently, men and women display different responses to androgen supplementation treatment. Post-menopausal women may particularly benefit from testosterone supplementation therapy. Future studies should further clarify the optimal dose and route of administration of testosterone, and more women should be included in clinical trials, in order to identify novel gender-specific targets, and finally to develop therapeutic strategies.
SpoletiniIVitaleCMalorniW. Sex differences in drug effects: interaction with sex hormones in adult life. Handb Exp Pharmacol2012; 214: 91–105.
2.
FranconiFCarruCSpoletiniI. A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics. Ther Deliv2012; 2: 1437–1453.
3.
MendelsohnMEKarasRH. Molecular and cellular basis of cardiovascular gender differences. Science2005; 308: 1583–1587.
4.
RuigeJBMahmoudAMDe BacquerD. Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart2012; 97: 870–875.
5.
RosanoGMCornoldiAFiniM. Effects of androgens on the cardiovascular system. J Endocrinol Invest2005; 28: 32–38.
EnglishKMMandourOSteedsRP. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J2000; 21: 890–894.
8.
RosanoGMSheibanIMassaroR. Low testosterone levels are associated with coronary artery disease in male patients with angina. Int J Impot Res2007; 19: 176–182.
9.
VitaleCMendelsohnMERosanoGM. Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol2009; 6: 532–542.
10.
ZhengHYLiYDaiW. Imbalance of testosterone/estradiol promotes male CHD development. Biomed Mater Eng2012; 22: 179–185.
11.
JonesRDHugh JonesTChannerKS. The influence of testosterone upon vascular reactivity. Eur J Endocrinol2004; 151: 29–37.
12.
McCrohonJADeathAKNakhlaS. Androgen receptor expression is greater in macrophages from male than from female donors. A sex difference with implications for atherogenesis. Circulation2000; 101: 224–226.
13.
VillablancaACJayachandranMBankaC. Atherosclerosis and sex hormones: current concepts. Clin Sci (Lond)2012; 119: 493–513.
14.
McCredieRJMcCrohonJATurnerL. Vascular reactivity is impaired in genetic females taking high-dose androgens. J Am Coll Cardiol1998; 32: 1331–1335.
15.
WorboysSKotsopoulosDTeedeH. Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen. J Clin Endocrinol Metab2001; 86: 158–161.
16.
PasqualiRVicennatiVGambineriA. Hormones and pathophysiology of obesity. Eat Weight Disord2001; 6: 9–20.
17.
MammiCCalanchiniMAntelmiA. Androgens and adipose tissue in males: a complex and reciprocal interplay. Int J Endocrinol2012; 2012: 789653–789653.
18.
ZmudaJMCauleyJAKriskaA. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. Am J Epidemiol1997; 146: 609–617.
19.
MontalciniTMigliaccioVFerroY. Androgens for postmenopausal women's health?Endocrine2012; 42: 514–520.
20.
GohHHLokeDFRatnamSS. The impact of long-term testosterone replacement therapy on lipid and lipoprotein profiles in women. Maturitas1995; 21: 65–70.
21.
CoronaGRastrelliGVignozziL. Testosterone, cardiovascular disease and the metabolic syndrome. Best Pract Res Clin Endocrinol Metab2012; 25: 337–353.
22.
NaessenTBergquistJLindL. Higher endogenous estrogen levels in 70-year-old women and men: an endogenous response to counteract developing atherosclerosis?Menopause2012; 19: 1322–1328.
23.
BruckBBrehmeUGugelN. Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol1997; 17: 2192–2199.
24.
von DehnGvon DehnOVolkerW. Atherosclerosis in apolipoprotein E-deficient mice is decreased by the suppression of endogenous sex hormones. Horm Metab Res2001; 33: 110–114.
25.
AlexandersenPHaarboJByrjalsenI. Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res1999; 84: 813–819.
26.
AdamsMRWilliamsJKKaplanJR. Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arterioscler Thromb Vasc Biol1995; 15: 562–570.
27.
KhawKT. Comparison of the early outcome of acute myocardial infarction in women and men. N Engl J Med1998; 338: 1543; author reply 4–1543; author reply 4.
28.
KapoorDGoodwinEChannerKS. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol2006; 154: 899–906.
29.
MullerMvan der SchouwYTThijssenJH. Endogenous sex hormones and cardiovascular disease in men. J Clin Endocrinol Metab2003; 88: 5076–5086.
30.
Barrett-ConnorEGoodman-GruenD. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. Bmj1995; 311: 1193–1196.
31.
PhillipsGBPinkernellBHJingTY. Relationship between serum sex hormones and coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol1997; 17: 695–701.
32.
BerniniGPSgroMMorettiA. Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab1999; 84: 2008–2012.
33.
ChangAYAbdullahSMJainT. Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study. J Am Coll Cardiol2007; 49: 109–116.
34.
SewdarsenMVythilingumSJialalI. Abnormalities in sex hormones are a risk factor for premature manifestation of coronary artery disease in South African Indian men. Atherosclerosis1990; 83: 111–117.
35.
PhillipsGBPinkernellBHJingTY. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb1994; 14: 701–706.
36.
Barrett-ConnorEKhawKT. Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation1988; 78: 539–545.
37.
Barrett-ConnorEKhawKTYenSS. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med1986; 315: 1519–1524.
38.
HautanenAManttariMManninenV. Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study. Atherosclerosis1994; 105: 191–200.
39.
JeppesenLLJorgensenHSNakayamaH. Decreased serum testosterone in men with acute ischemic stroke. Arterioscler Thromb Vasc Biol1996; 16: 749–754.
40.
D'AmicoAVChenMHRenshawAA. Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer. Cancer2008; 113: 3290–3297.
41.
RosanoGM. Androgens and coronary artery disease.. A sex-specific effect of sex hormones?Eur Heart J2000; 21: 868–871.
42.
YasuiTMatsuiSTaniA. Androgen in postmenopausal women. J Med Invest2012; 59: 12–27.
43.
IellamoFVolterraniMCaminitiG. Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. J Am Coll Cardiol2012; 56: 1310–1316.
44.
SaccaL. Heart failure as a multiple hormonal deficiency syndrome. Circ Heart Fail2009; 2: 151–156.
45.
CaminitiGVolterraniMIellamoF. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol2009; 54: 919–927.
46.
CarsonCC3rdRosanoG. Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data. J Sex Med2012; 9: 54–67.
47.
ArmstrongPWEzekowitzJA. Testosterone therapy in women with heart failure “why can't a woman be more like a man?”. J Am Coll Cardiol2012; 56: 1317–1319.
